Skip to main content

Table 2 Probability of recurrence of patients from the two trial arms, sorted by tumour size, at different follow-up times (95% confidence intervals in parenthesis)

From: Comparative benefit from small tumour size and adjuvant chemotherapy: clues for explaining breast cancer mortality decline

 

Years of follow-up

5

10

15

Controls, T1

0.46 (0.38-0.54)

0.61 (0.52-0.69)

0.67 (0.59-0.75)

Controls, T2/T3

0.62 (0.53-0.70)

0.72 (0.64-0.80)

0.76 (0.67-0.83)

CMF, T1

0.38 (0.30-0.46)

0.51 (0.42-0.59)

0.59 (0.50-0.67)

CMF, T2/T3

0.46 (0.38-0.55)

0.57 (0.49-0.65)

0.62 (0.54-0.70)